Assessing murine resistance artery function using pressure myography

Journal of Visualized Experiments

Volumn , Issue 76, 2013, Pages

  Shahid, M ^a   Buys, S E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Anatomy; Animal model; Bioengineering; Biomedical Engineering; Biophysics; Cardiology; Cardiovascular System; Hematology; Issue 76; Medicine; Mice; Myograph; Myography; NO cGMP signaling; Physiology; Pressure myography; Resistance arteries; Signaling; Vascular Diseases

Indexed keywords

EID: 84878842529     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/50328     Document Type: Article

References (14)

1. Bridges, L.E., Williams, C.L., Pointer, M.A., & Awumey, E.M. Mesenteric artery contraction and relaxation studies using automated wire myography. J. Vis.Exp. (55), e3119, doi:10.3791/3119 (2011).
2. Arribas, S.M., Daly, C.J., & McGrath, I.C. Measurements of vascular remodeling by confocal microscopy. Methods Enzymol. 307 246-273 (1999).
3. Lei, C., Yu, B., et al. Inhaled Nitric Oxide Attenuates the Adverse Effects of Transfusing Stored Syngeneic Erythrocytes in Mice with Endothelial Dysfunction after Hemorrhagic Shock. Anesthesiology., (2012).
4. Buys, E.S., Cauwels A, et al. sGCα1β1 attenuates cardiac dysfunction and mortality in murine inflammatory shock models. Am. J. Physiol. Heart Circ. Physiol. 297 (2), H654-663 (2009).
5. Buys, E.S., Sips, P, et al. Gender-specific hypertension and responsiveness to nitric oxide in sGCα1 knockout mice. Cardiovasc. Res. 79 (1), 179-186 (2008).
6. Panza, J.A., Quyyumi, A.A., Brush, J.E., Jr., & Epstein, S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N. Engl. J. Med. 323 (1), 22-27 (1990).
7. Huang, P.L., Huang Z, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 377 (6546), 239-242. (1995).
8. Friebe, A. & Koesling, D. The function of NO-sensitive guanylyl cyclase: what we can learn from genetic mouse models. Nitric Oxide. 21 (3-4), 149-156 (2009).
9. Ehret, G.B., Munroe, P.B., et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 478 (7367), 103-109 (2011).
10. Buys, E.S., Raher, M.J., et al. Genetic modifiers of hypertension in soluble guanylate cyclase alpha1-deficient mice. J. Clin. Invest. 122 (6), 2316-2325 (2012).
11. Kauffenstein, G., Laher, I., Matrougui, K., Guerineau, N.C., & Henrion, D. Emerging role of G protein-coupled receptors in microvascular myogenic tone. Cardiovascular Research. 95 (2), 223-232 (2012).
12. Ruilope, L.M. Hypertension in 2010: Blood pressure and the kidney. Nat. Rev. Nephrol. 7 (2), 73-74 (2011).
13. Michael, S.K., Surks, H.K., et al. High blood pressure arising from a defect in vascular function. Proc. Natl. Acad. Sci. U.S.A. 105 (18), 6702-6707 (2008).
14. Mendelsohn, M.E. In hypertension, the kidney is not always the heart of the matter. J. Clin. Invest. 115 (4), 840-844 (2005).